Drug:
Reaction: DEATH
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138759 |
GB |
1 | |
Death, |
||||
DARBEPOETIN ALFA, |
||||
| 2 | 25138765 |
US |
2 | |
Death, |
||||
ADALIMUMAB, ETANERCEPT, |
||||
| 3 | 25138784 |
AU |
||
Death, Toxic epidermal necrolysis, |
||||
APALUTAMIDE, |
||||
| 4 | 25138793 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 5 | 25138834 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 6 | 25138866 |
CN |
||
Death, |
||||
DURVALUMAB, |
||||
| 7 | 25138928 |
US |
||
Death, |
||||
BENRALIZUMAB, |
||||
| 8 | 25138943 |
NL |
64 | 2 |
Death, |
||||
AMANTADINE HYDROCHLORIDE, |
||||
| 9 | 25138973 |
JP |
46 | 2 |
Death, Malignant neoplasm progression, |
||||
LENVATINIB, PEMBROLIZUMAB, |
||||
| 10 | 25138983 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 11 | 25139043 |
IN |
68 | 1 |
Death, |
||||
ATEZOLIZUMAB, |
||||
| 12 | 25139065 |
AU |
||
Death, |
||||
DENOSUMAB, |
||||
| 13 | 25139087 |
TW |
||
Death, |
||||
DURVALUMAB, |
||||
| 14 | 25139108 |
US |
86 | 2 |
Death, |
||||
PERFLUOROHEXYLOCTANE, LIFITEGRAST, GABAPENTIN, INSULIN DETEMIR, LOSARTAN, APIXABAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CARVEDILOL, |
||||
| 15 | 25139120 |
US |
||
Death, |
||||
| 16 | 25139126 |
US |
||
Death, |
||||
| 17 | 25139153 |
CA |
2 | |
Death, |
||||
RANIBIZUMAB, |
||||
| 18 | 25139166 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 19 | 25139170 |
US |
69 | 2 |
Death, |
||||
APIXABAN, |
||||
| 20 | 25139219 |
US |
64 | |
Death, |
||||
OSIMERTINIB, |
||||
| 21 | 25139220 |
US |
||
Death, |
||||
CAPIVASERTIB, |
||||
| 22 | 25139257 |
US |
||
Death, |
||||
| 23 | 25139262 |
US |
||
Death, |
||||
BENRALIZUMAB, |
||||
| 24 | 25139278 |
US |
||
Death, |
||||
OSIMERTINIB, |
||||
| 25 | 25139285 |
US |
||
Death, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 26 | 25139294 |
IN |
67 | 2 |
Death, |
||||
ATEZOLIZUMAB, |
||||
| 27 | 25139301 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 28 | 25139329 |
US |
1 | |
Death, |
||||
| 29 | 25139405 |
US |
||
Death, |
||||
ACALABRUTINIB, |
||||
| 30 | 25139419 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 31 | 25139420 |
US |
||
Death, |
||||
CAPIVASERTIB, |
||||
| 32 | 25139435 |
US |
93 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 33 | 25139461 |
US |
||
Death, |
||||
OSIMERTINIB, |
||||
| 34 | 25139500 |
US |
63 | |
Death, |
||||
BENRALIZUMAB, |
||||
| 35 | 25139501 |
US |
2 | |
Death, |
||||
PIMAVANSERIN TARTRATE, DROXIDOPA, ISTRADEFYLLINE, MIRABEGRON, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL TARTRATE, METOPROLOL, ERGOCALCIFEROL, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 36 | 25139510 |
GB |
82 | 2 |
Death, |
||||
LANREOTIDE ACETATE, |
||||
| 37 | 25139518 |
US |
53 | |
Death, |
||||
OSIMERTINIB, |
||||
| 38 | 25139539 |
US |
1 | |
Death, Gastrointestinal disorder, |
||||
SEMAGLUTIDE, |
||||
| 39 | 25139575 |
GB |
76 | 2 |
Contraindicated product administered, Death, Cardiac disorder, |
||||
| 40 | 25139580 |
US |
1 | |
Death, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 41 | 25139594 |
US |
1 | |
Death, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, TICAGRELOR, BUPROPION HYDROCHLORIDE, BUPROPION, CARBIDOPA LEVODOPA, DONEPEZIL HYDROCHLORIDE, GABAPENTIN, LEVOTHYROXINE, LISINOPRIL, MEMANTINE, MEMANTINE HYDROCHLORIDE, ROPINIROLE, SERTRALINE, |
||||
| 42 | 25139610 |
US |
73 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 43 | 25139629 |
FR |
37 | 1 |
Death, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 44 | 25139631 |
US |
84 | 1 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 45 | 25139632 |
US |
84 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 46 | 25139646 |
US |
||
Death, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 47 | 25139679 |
US |
75 | 2 |
Death, |
||||
APIXABAN, |
||||
| 48 | 25139703 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 49 | 25139710 |
JP |
||
Death, |
||||
| 50 | 25139730 |
US |
||
Death, |
||||
| 51 | 25139804 |
JP |
||
Death, |
||||
| 52 | 25139844 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 53 | 25139858 |
SC |
2 | |
Death, |
||||
RIBOCICLIB, LETROZOLE, |
||||
| 54 | 25139965 |
TW |
||
Death, |
||||
DURVALUMAB, |
||||
| 55 | 25139998 |
GB |
2 | |
Death, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 56 | 25140000 |
JP |
72 | 2 |
Death, Triple negative breast cancer, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 57 | 25140029 |
AU |
||
Death, |
||||
DENOSUMAB, |
||||
| 58 | 25140031 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 59 | 25140040 |
US |
60 | 1 |
Death, |
||||
DABRAFENIB, TRAMETINIB, |
||||
| 60 | 25140080 |
AU |
1 | |
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 61 | 25140118 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 62 | 25140121 |
CN |
||
Death, |
||||
DURVALUMAB, |
||||
| 63 | 25140139 |
CA |
58 | 1 |
Death, |
||||
| 64 | 25140217 |
AU |
||
Death, Hospitalisation, |
||||
DENOSUMAB, |
||||
| 65 | 25140233 |
GB |
1 | |
Death, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 66 | 25140264 |
US |
1 | |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 67 | 25140272 |
SG |
69 | 2 |
Death, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 68 | 25140307 |
NL |
||
Death, |
||||
DALFAMPRIDINE, |
||||
| 69 | 25140343 |
CA |
1 | |
Death, Palliative care, Off label use, |
||||
LANREOTIDE ACETATE, OCTREOTIDE ACETATE, PERINDOPRIL ERBUMINE, BRINZOLAMIDE, BISOPROLOL FUMARATE, RIVAROXABAN, FUROSEMIDE, CARBOXYMETHYLCELLULOSE SODIUM, |
||||
| 70 | 25140433 |
JP |
61 | 2 |
Death, Arthralgia, Hypothyroidism, |
||||
LENVATINIB, PEMBROLIZUMAB, |
||||
| 71 | 25140478 |
US |
55 | 2 |
Death, |
||||
APIXABAN, |
||||
| 72 | 25140480 |
US |
88 | 2 |
Death, |
||||
APIXABAN, |
||||
| 73 | 25140481 |
US |
74 | 1 |
Death, |
||||
APIXABAN, |
||||
| 74 | 25140508 |
CA |
60 | 1 |
Death, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 75 | 25140593 |
DE |
||
Death, |
||||
OPICAPONE, |
||||
| 76 | 25140639 |
JP |
||
Death, |
||||
TEZEPELUMAB-EKKO, |
||||
| 77 | 25140642 |
US |
67 | 2 |
Death, |
||||
RIOCIGUAT, RIOCIGUAT, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BISMUTH SUBSALICYLATE, LORAZEPAM, SERTRALINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, PANTOPRAZOLE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, OIL, BIOTIN, HAIR, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, CALCIUM, MAGNESIUM, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, |
||||
| 78 | 25140649 |
JP |
||
Death, |
||||
| 79 | 25140652 |
CA |
49 | 2 |
Death, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, ACYCLOVIR, RABEPRAZOLE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 80 | 25140665 |
US |
1 | |
Death, |
||||
RIOCIGUAT, |
||||
| 81 | 25140682 |
US |
2 | |
Death, Hospitalisation, |
||||
SITAGLIPTIN, |
||||
| 82 | 25140685 |
CA |
68 | 1 |
Death, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 83 | 25140695 |
|||
Death, |
||||
PEMIGATINIB, |
||||
| 84 | 25140699 |
US |
||
Death, Chronic kidney disease, Bone density decreased, Tooth loss, |
||||
| 85 | 25140700 |
US |
83 | 1 |
Death, |
||||
REGORAFENIB, |
||||
| 86 | 25140716 |
US |
2 | |
Death, |
||||
NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, |
||||
| 87 | 25140727 |
US |
65 | 1 |
Death, |
||||
LENALIDOMIDE, IXAZOMIB, |
||||
| 88 | 25140797 |
US |
61 | |
Death, |
||||
RITUXIMAB, |
||||
| 89 | 25140798 |
US |
61 | |
Death, |
||||
RITUXIMAB, |
||||
| 90 | 25140801 |
US |
61 | |
Death, |
||||
RITUXIMAB, |
||||
| 91 | 25140865 |
JP |
60 | 2 |
Death, Diarrhoea, Malignant neoplasm progression, |
||||
LENVATINIB, PEMBROLIZUMAB, |
||||
| 92 | 25140911 |
PL |
61 | 2 |
Death, Pleural effusion, Post procedural inflammation, Purulent discharge, Depressed mood, Dysphagia, Body mass index decreased, Transaminases increased, Hypophagia, Catheter site discharge, General physical health deterioration, Osteosclerosis, Headache, Asthenia, Pyrexia, |
||||
ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 93 | 25140947 |
|||
Death, |
||||
RISANKIZUMAB-RZAA, |
||||
| 94 | 25140980 |
US |
72 | 1 |
Death, Atrial fibrillation, Swelling, Speech disorder, Blood pressure abnormal, Oedema peripheral, Musculoskeletal stiffness, Dysphagia, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 95 | 25141005 |
US |
64 | 1 |
Death, |
||||
LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SEMAGLUTIDE, PIOGLITAZONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 96 | 25141037 |
|||
Death, |
||||
MACITENTAN, |
||||
| 97 | 25141040 |
|||
Death, |
||||
DIROXIMEL FUMARATE, |
||||
| 98 | 25141074 |
US |
70 | 2 |
Death, |
||||
BREXPIPRAZOLE, |
||||
| 99 | 25141106 |
65 | 1 | |
Death, |
||||
ENCORAFENIB, |
||||
| 100 | 25141111 |
89 | 2 | |
Death, |
||||
COLLAGENASE SANTYL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28